Related Experiment Video
Updated: Aug 15, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The importance of blood pressure control in the patient with diabetes
1Departments of Preventative and Internal Medicine, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
Insights
Aggressively treating hypertension in diabetes mellitus patients is crucial for preventing kidney and heart disease. New vasodilating beta-blockers offer benefits beyond blood pressure control, aiding in achieving treatment goals.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Diabetes mellitus increases the risk of renal and cardiovascular disease, particularly with blood pressure above 130/80 mm Hg.
- New guidelines recommend more aggressive hypertension management for individuals with diabetes.
Purpose of the Study:
- To review the efficacy of various antihypertensive agents in type 2 diabetes.
- To highlight the benefits of new vasodilating beta-blockers in managing hypertension and cardiovascular risk in diabetic patients.
Main Methods:
- Review of clinical evidence and study findings on antihypertensive agents in type 2 diabetes.
- Analysis of the role of specific drug classes including ACE inhibitors, ARBs, diuretics, beta-blockers, and calcium-channel blockers.
- Evaluation of the advantages of vasodilating beta-blockers.
Main Results:
- Multiple antihypertensive agents (ACE inhibitors, ARBs, diuretics, beta-blockers, calcium-channel blockers) are effective in type 2 diabetes.
- Combination therapy is often necessary to achieve target blood pressure (<130/80 mm Hg) and reduce cardiovascular and renal events.
- New vasodilating beta-blockers provide cardiovascular risk reduction without adverse metabolic effects.
Conclusions:
- Aggressive hypertension treatment significantly benefits patients with diabetes mellitus.
- Clinicians should be aware of the need for intensified blood pressure management.
- Newer vasodilating beta-blockers show promise in achieving blood pressure targets and improving cardiovascular outcomes.
Abstract:
In individuals with diabetes mellitus, higher risk for renal and cardiovascular disease is seen with blood pressure levels >130/80 mm Hg. Findings of several studies, as well as new guidelines, indicate that individuals with diabetes will benefit from more aggressive treatment of hypertension. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, diuretics, beta-adrenoceptor blockers, and calcium-channel blockers are effective antihypertensive agents in type 2 diabetes. Moreover, combinations of these agents are frequently required to reach the target blood pressure of <130/80 mm Hg and reduce risk for renal and cardiovascular events. All of these agents have demonstrated benefits in treating patients. Clinical evidence also indicates that the new vasodilating beta-blockers offer advantages beyond blood pressure control, including cardiovascular risk reduction without exacerbating metabolic parameters. With increased awareness of the need for aggressive treatment of hypertension, clinicians can provide significant benefit to their patients with diabetes. The new beta-blockers may play an important role in achieving blood pressure goals.
Related Concept Videos
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Factors affecting Blood pressure
Physiological Factors:
Errors occurring during blood pressure monitoring
Several factors...
Blood Pressure
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Nephropathy

